Skip to content

Use of Blood Flow Restriction Therapy Following ACL Tear

Use of Blood Flow Restriction (BFR) Therapy in Peri-operative Rehabilitation Following Anterior Cruciate Ligament Tear

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04374968
Enrollment
50
Registered
2020-05-05
Start date
2020-07-28
Completion date
2022-05-01
Last updated
2023-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Tear, Knee Injuries, Sport Injury

Brief summary

Evaluating the use of peri-operative blood flow restriction therapy surrounding anterior cruciate ligament tear

Detailed description

The purpose of this study is to examine the effect of utilizing blood flow restriction (BFR) therapy both before and after anterior cruciate ligament reconstruction (ACLR) following a tear. BFR has been proposed to work by restricting arterial inflow leading to an oxygen depleted environment and the ability to induce muscle adaption at lower maximum repetition via reactive hyperemia. Muscle atrophy occurs following ACL tear and reconstruction. Thus, physical therapy is used in the peri-operative period to regain strength with the ultimate goal of returning to activity. The goal of this investigation is to determine if using BFR during perioperative therapy would lead to increased and expedited strength gains. Additionally we would like to determine if BFR helps patients to pass the standard rehabilitative functional tests and return to play sooner. We will also look at patient reported outcomes metrics and pain scores to determine if BFR has a significant impact on the patient experience surrounding ACL tear and reconstruction.

Interventions

DEVICEBlood flood restriction cuff

Blood flow restriction cuffs will be used as an augment to physical therapy

Sponsors

Henry Ford Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Participant and investigator will be aware of treatment arm allocation. Outcomes will be assessed in a masked fashion

Intervention model description

Parallel randomized controlled trial with a treatment and control group

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* ACL tear undergoing reconstruction

Exclusion criteria

* History of pulmonary embolism * History of deep vein thrombosis * Family history of PE/DVT * Hypercoaguable disorder * Multiligamentous knee injury * Neurovascular injury * Peripheral vascular disease * Unable to complete physical therapy * Unable to tolerate blood flow restriction

Design outcomes

Primary

MeasureTime frameDescription
Quadriceps StrengthThree monthsQuadriceps strength via handheld dynamometer

Secondary

MeasureTime frameDescription
Quadriceps Strengthsix monthsQuadriceps strength via handheld dynamometer
Knee range of motionthree monthsKnee range of motion via goniometer
Patient reported outcome measurement information systemThree monthsPatient reported outcomes measurement information system score on patient physical function, scale 0-100 with higher scores better
international knee documentation committee questionnairethree monthsinternational knee documentation committee questionnaire, scale 0-100 with higher scores better
Pain scoresthree monthsVisual analog scale pain scores, scale 0-10 higher is more pain
Patient reported outcomes measurement information systemSix monthsPatient reported outcomes measurement information system score on patient physical function, scale 0-100 with higher scores better

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026